Figure 7. Effects of PEDF-R inhibition on CRX expression. A: Schematic illustration of the treatment protocol of wild-type mouse retinal explants with vehicle (DMSO), atglistatin (100
µM), H105A peptide (20 nM), or a combination of atglistatin and H105A for 48 h followed by CRX detection. B: Representative images of regions of interest (ROIs) of treated retinal explants. Images are representative of four technical
replicates (ROIs) and four biological replicates (eyes) per condition. Mice were 3 months old. C: CRX mean fluorescence intensity (MFI) was measured within each ROI and normalized to the number of DAPI-positive nuclei;
each point represents one explant from one of three independent mice (n = 3). Data are shown as mean ± SD. Statistical significance
was determined by ordinary one-way analysis of variance multiple comparisons: ns, not significant; **p < 0.01.
